Sacroiliac Joint Dysfunction
Investigational use for SI joint mechanical pain with positive provocation tests; no clinical study of leech therapy was identified.
Patient Summary
- Is this FDA-cleared for this use?
- Not FDA-cleared for sacroiliac joint dysfunction. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use here is investigational.
- What evidence exists?
- Tier C (investigational). No clinical study of leech therapy for sacroiliac joint dysfunction was identified. Evidence-based care for sacroiliac joint dysfunction: structured physical therapy with pelvic stabilization, core and gluteal strengthening, manual therapy, sacroiliac belt, NSAIDs, image-guided sacroiliac joint injection (diagnostic and therapeutic), and (refractory) radiofrequency ablation of lateral branch nerves or sacroiliac joint fusion. Workup must exclude inflammatory sacroiliitis from spondyloarthropathy (ankylosing spondylitis, psoriatic arthritis), which has different treatment (anti-inflammatories, biologics).
- Main risks
- Bleeding from each bite site for 6 to 24 hours after detachment
- Bruising over the sacroiliac region for 5 to 10 days
- Local skin or, rarely, Aeromonas hydrophila infection
- Allergic reaction to leech saliva (uncommon)
- Worsening sacroiliac pain from local irritation
- Delay of image-guided sacroiliac joint injection - the diagnostic gold standard
- Delay of workup for inflammatory sacroiliitis (which needs biologic therapy, not procedural)
- Placebo response masking lumbar radiculopathy, hip pathology, or pelvic floor dysfunction
- Who should not consider this
- Patients with suspected inflammatory sacroiliitis (HLA-B27, family history, morning stiffness, alternating buttock pain) - this needs rheumatology workup and biologic therapy
- Patients with red-flag features (fever, weight loss, night pain, cancer history)
- Patients with lumbar radiculopathy, hip pathology, or pelvic floor dysfunction as alternative diagnoses
- Patients who have not completed a structured physical therapy program with pelvic stabilization
- Patients who have not tried image-guided sacroiliac joint injection (diagnostic)
- Patients on anticoagulants, with hemophilia, or with anemia
- Patients with active dermatitis or broken skin over the sacroiliac region
- What to ask your clinician
- Has inflammatory sacroiliitis (ankylosing spondylitis, psoriatic arthritis, IBD-related) been excluded?
- Have I been worked up for lumbar radiculopathy, hip pathology, and pelvic floor dysfunction?
- Have I completed a structured physical therapy program with pelvic stabilization and gluteal strengthening?
- Have I tried image-guided sacroiliac joint injection - both diagnostic and therapeutic?
- Am I a candidate for radiofrequency ablation or sacroiliac joint fusion for refractory cases?
- Where exactly will leeches be placed - confirm strictly over the posterior sacroiliac region?
- What is the Aeromonas-prevention protocol?
- When to seek urgent care
- Cauda equina symptoms - bowel or bladder dysfunction, saddle anesthesia, bilateral leg weakness (911)
- Fever, weight loss, or night sweats with back pain (possible infection or malignancy)
- Sudden severe pain after a fall or trauma
- Inflammatory features - morning stiffness over 30 minutes, alternating buttock pain, peripheral arthritis (rheumatology referral)
- Bleeding from a bite site lasting more than 24 hours
- Spreading redness, pus, or warmth at the bite site
- Hives, facial or throat swelling, or breathing difficulty
What this does NOT mean
- This is not FDA-cleared for sacroiliac joint dysfunction.
- No clinical study of leech therapy for this condition was identified, so efficacy is unestablished.
- It does not address inflammatory sacroiliitis from spondyloarthropathy, which needs biologic therapy.
- It does not replace image-guided sacroiliac joint injection - the diagnostic gold standard and a therapeutic option.
- Pelvic stabilization exercise has the strongest non-procedural evidence and should not be skipped.
Safety cross-references
Clinical Profile
- Category
- Musculoskeletal
- ICD-10
- M53.3, M46.1
- Safety tier
- Low
Evidence Summary
Sacroiliac joint dysfunction is diagnosed when three or more provocation tests (FABER, Gaenslen, compression, distraction, thigh thrust, sacral thrust) are positive per the Laslett criteria. Conventional management includes manual therapy, sacroiliac belts, and image-guided steroid injection with a moderate short-term response rate. No clinical study of leech therapy for sacroiliac joint dysfunction was identified in PubMed, Europe PMC, Crossref or ClinicalTrials.gov, or in the Baskova and Isakhanyan 2004 monograph. The nearest controlled evidence found is one small unblinded randomized trial in chronic low back pain (Hohmann 2018, 44 patients analysed), which did not target the sacroiliac joint; use here is investigational and mechanistic only. Inflammatory sacroiliitis (axial spondyloarthropathy) is a critical exclusion via HLA-B27 and MRI.
Treatment specifics
How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: where the society's reference books describe a protocol, it is shown in the clinician view — switch the audience selector in the top bar to “Clinician”.)
Contraindications
- Hemophilia or another bleeding disorder
- Taking anticoagulants (blood thinners such as warfarin or heparin)
- Anemia or suppressed blood formation
- Low blood pressure, shock, collapse or fainting
- Severe wasting (cachexia)
- Intolerance of leeches or a history of severe allergic reactions
- Pregnancy
- Stomach or duodenal ulcer, erosive gastritis
- Acute infectious disease or high fever
- Severe unstable illness, markedly weakened immunity (for example during chemotherapy) or HIV infection
- Drinking alcohol at the time of treatment
- No consent from the patient
- Axial spondyloarthritis without rheumatologic management
- Active SI joint infection
Related Conditions
Lumbosacral Radiculopathy (Non-Discogenic)
Investigational use for lumbosacral radicular pain without disc herniation (foraminal stenosis, facet hypertrophy, lateral recess); no study specific to this subtype was identified.
Piriformis Syndrome (Isolated, FAIR-Positive)
Investigational use for isolated piriformis syndrome (positive FAIR test, lumbar pathology excluded); no clinical study of leech therapy was identified.
Pubic Symphysis Dysfunction (Non-Pregnancy)
Investigational use for non-pregnancy pubic symphysis dysfunction, including osteitis pubis; no clinical study of leech therapy was identified.
Knee Osteoarthritis
Off-label use; several small RCTs in knee OA report pain and function improvement with leeches versus NSAID gel, sham leech or TENS, though results against sham and TENS are mixed, and a 2022 trial against physiotherapy found no therapeutic effect.